| Control group (n = 123) | HD group (n = 206) | ||||
---|---|---|---|---|---|---|
Sex (n, (%)) | All | Male 77 (62.6) | Female 46 (37.4) | All | Male 132 (64.1) | Female 74 (35.9) |
Age (years) | 67.0 | 66.6 | 67.6 | 66.4 | 66.2 | 66.6 |
BMI | 23.7 | 24.1 | 23.1 | 22.5 | 22.7 | 22.1 |
Creatinine (mg/dL) | 0.84 | 0.92 | 0.71 | 10.99 | 11.51 | 10.08 |
Diabetes mellitus (n, (%)) | 17 (16.3)* | 13 (20.0) | 4 (10.3) | 90 (43.7) | 65 (49.3) | 25 (33.8) |
Hypertension (n, (%)) | 47 (45.2)* | 33 (50.8) | 14 (35.9) | 84 (40.8) | 56 (42.4) | 28 (37.8) |
Malignant tumor (n, (%)) | 10 (9.6)* | 8 (12.3) | 2 (5.1) | 29 (14.1) | 18 (13.6) | 11 (14.9) |
Cerebrovascular disease (n, (%)) | 6 (5.8)* | 5 (7.7) | 1 (2.6) | 44 (21.4) | 32 (24.2) | 12 (16.2) |
Cardiovascular disease (n, (%)) | 4 (3.8)* | 3 (4.6) | 1 (2.6) | 41 (19.9) | 29 (22.0) | 12 (16.2) |
COPD (n, (%)) | 9 (8.7)* | 7 (10.8) | 2 (5.1) | 12 (5.8) | 3 (2.3) | 9 (12.2) |